Martin Reck

International Lung Cancer Summit Verified account @LungSummit · Oct 6

DLL3-targeted TCEs and ADCs have opened new questions in SCLC: whom to treat, in what order, and how to manage a different kind of toxicity.

Solange Peters @peters_solange, Martin Reck @MartinReck2, Giannis Mountzios @g_mountzios and Noemí Reguart @NReguart will work through them at ESMO 2026 in Madrid on Sunday 25 October, 13:00 to 14:30. Join us in the Salamanca Auditorium, Hall 10, for 2 CME credits. We would love to see you there, so save the slot before your Sunday fills up 🙂

Add it to your calendar: lungsummit.org/calendar/sclc-…
Programme and faculty: lungsummit.org/featured/sclc-…

#ESMO26 #SCLC #LungCancer

View quoted post on X

OncoAlert Verified account @OncoAlert · Sep 3

The OncoAlert #WCLC26 Top 10 Deep Dive! Abstract to be presented Next week

OA04.02Neoadjuvant Durvalumab + Chemotherapy for Resectable/Borderline Resectable Stage IIB-IIIB NSCLC: MDT-BRIDGE Primary Analysis

Neoadjuvant Durvalumab + Chemotherapy for Resectable/Borderline Resectable Stage IIB–IIIB NSCLC: MDT-BRIDGE Primary Analysis

🫁 Phase II global trial: 2 cycles neoadjuvant durvalumab + chemotherapy, then MDT reassessment routed patients to surgery or chemoradiotherapy, followed by durvalumab. Primary endpoint resection rate.

➡️ Resection rate 74.6% (95% CI 66.7–81.6); R0 96.2%
➡️ 92.3% received surgery or CRT; 82.4% went on to adjuvant or consolidation durvalumab
➡️ Resectable at reassessment: pCR 27.3%, 12-month EFS 90.1%; unresectable: 12-month PFS 75.1%
✅ Close MDT follow-up let most patients reach curative-intent treatment, with safety consistent with prior studies.

🎙️ Martin Reck
👥 Ernest Nadal · Carl Gay · Nicolas Girard · Andrea Filippi · Linda Martin · Cordula Petersen · David Cairns · Margarita Majem · Andrea Ardizzoni · Rosa Álvarez Álvarez · Andrew Robinson · Benoit Roch · Arnaud Boyer · Ilaria Attili · Lei Li · Ignacio Diaz Perez · Matteo Giaj Levra · Nefeli Georgoulia · Jonathan Spicer

⭐️ These Slides were created based on publicly released #WCLC26 abstracts and to be presented at WCLC! These are not Speaker Slides

@MartinReck2
@NadalErnest
@nicogirardcurie
@AndrearicFili
@LindaMThoracic
@DoctorJSpicer

Pinging our OncoAlert Lung Cancer Faculty
@peters_solange
@christine_lovly
@GlopesMd
@DrSanjayPopat
@StephenVLiu
@HenningWillers
@HHorinouchi
@BRicciutiMD
@PercyLeeMD
@jillfeldman4
@bensolomon1
@Latinamd
@DrJNaidoo
@barlesi
@UOzkerim
@FernandoOnco
@DrMirallas
@VanitaNoronha
@NarjustFlorezMD
@MartinReck2

View quoted post on X

Yago Garitaonaindía Verified account @YGaritaonaindia · Jun 30

It has been a true privilege to be part of this project as an author, under the mentorship and trust of @MARIANOPROVENCI, a worldwide reference in the field and a mentor who I deeply admire 🙏

Thankful to all co-authors for their invaluable expertise and input: @HwakeleeMD @MartinReck2 @FordePatrick Tina Cascone & @DoctorJSpicer

In @NatRevClinOncol 📖

View quoted post on X